DOI:
10.1055/s-00033990
TH Open
LinksClose Window
References
Griesinger F, Laskin JJ, Pavlakis N.
Safety of first-line bevacizumab-based therapy with concomitant cardiovascular or anticoagulation medication in advanced or recurrent non-squamous non-small cell lung cancer (NSCLC) in MO19390 (SAiL).
J Clin Oncol 2008;
26 (Suppl 15): 8049
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.